ABOS vs HUMA
Comparison between Acumen Pharmaceuticals Inc (ABOS, Company) and Humacyte Inc (HUMA, Company).
Both ABOS and HUMA are from the Healthcare sector.
5-Year PerformanceABOS has outperformed HUMA, delivering a return of -31.6% compared to -42.2%
ABOS vs HUMA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ABOS vs HUMA - Historical Returns
Returns include dividend reinvestment.
ABOS vs HUMA - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | ABOS | HUMA |
|---|---|---|
| 2026 | +10.89% | -25.25% |
| 2025 | +14.05% | -81.46% |
| 2024 | -59.34% | +74.74% |
| 2023 | -27.00% | +34.60% |
| 2022 | -19.76% | -71.49% |
| 2021 | -66.37% | -33.85% |
ABOS vs HUMA Drawdown Comparison
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The maximum drawdown for HUMA was -96.62%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current ABOS drawdown is -88.95%. The current HUMA drawdown is -95.71%.
| Rank | ABOS | HUMA |
|---|---|---|
| #1 | -95.56% Jul 2, 2021 - Apr 17, 2025 | -96.62% Sep 1, 2021 - Mar 30, 2026 |
Correlation
Correlation between ABOS and HUMA is 0.69 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks